<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>FGFR3 germline mutations cause <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">skeletal disorders</z:e> including <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, severe <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> with <z:hpo ids='HP_0001263'>developmental delay</z:hpo> and <z:hpo ids='HP_0000956'>acanthosis nigricans</z:hpo>, and <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001428'>Somatic mutations</z:hpo> of FGFR3 have been identified in <z:e sem="disease" ids="C0005684" disease_type="Neoplastic Process" abbrv="">bladder cancer</z:e>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, and other <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>FGFR3 mutations have also been detected in 40% of <z:e sem="disease" ids="C0022603" disease_type="Neoplastic Process" abbrv="">seborrheic keratoses</z:e> (SKs) of the hyperkeratotic and acanthotic subtype, which are very common benign <z:hpo ids='HP_0008069'>skin tumors</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Using a multiplex SNaPshot assay that covers 11 activating FGFR3 mutations, we investigated a series of 27 SKs of the adenoid subtype </plain></SENT>
<SENT sid="4" pm="."><plain>Mutations were detected in 23 of 27 (85%) adenoid SKs </plain></SENT>
<SENT sid="5" pm="."><plain>R248C mutations were the most frequent mutation type </plain></SENT>
<SENT sid="6" pm="."><plain>In two SKs, the A393E mutation was found, which has not been described in acanthotic and hyperkeratotic SKs so far </plain></SENT>
<SENT sid="7" pm="."><plain>Three adenoid SKs displayed two simultaneous FGFR3 mutations </plain></SENT>
<SENT sid="8" pm="."><plain>Adenoid SKs seem to be characterized by a higher frequency of FGFR3 mutations than hyperkeratotic and acanthotic SKs </plain></SENT>
<SENT sid="9" pm="."><plain>The mechanism for the high rate of somatic FGFR3 mutations in these benign <z:hpo ids='HP_0008069'>skin tumors</z:hpo> remains elusive, but UV light exposure may play a potential role, especially in the R248C mutations </plain></SENT>
</text></document>